强脉冲光在睑板腺功能障碍相关干眼治疗中的应用现状

Clinical Application Status of Intense Pulsed Light in Treatment of Meibomian Gland Dysfunction Associated with Dry Eye

睑板腺功能障碍(Meibomian Gland Dysfunction,MGD)是临床上常见的慢性炎症疾病,是导致干眼症(Dry Eye Disease,DED)的主要原因。强脉冲光(Intense Pulsed Light,IPL)作为治疗MGD及其相关干眼的一种新疗法,在眼科领域逐渐得到关注,其安全性和有效性也日益得到认可。随着临床治疗的需要和光疗技术的发展,IPL对MGD及其干眼的治疗呈现多样化的趋势。本文旨在对IPL作为一种独立的治疗方式或联合其他物理治疗方式在治疗MGD中的应用进展进行综述,并阐述IPL在治疗MGD中的应用现状,以期为临床治疗MGD提供一定的参考依据。

Meibomian gland dysfunction(MGD)is a clinically common chronic inflammatory disease,which is the major cause of dry eye disease(DED).As a novel therapy for meibomian gland dysfunction and relevant dry eye diseases,intense pulsed light(IPL)is getting more attention from ophthalmologists,and its safety and efficacy have been increasingly recognized.With the increasing demand for clinical treatment and the development of phototherapy technology,the treatment of MGD and relevant dry eye diseases by IPL shows a diversified trend.This paper aims to review the application progress of IPL as an independent therapy or combined with other physiotherapy methods,and expound the current application status of IPL in the treatment of MGD,in order to provide certain reference basis for clinical treatment of MGD.